Sep 102020
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– UK, London –  MiNA Therapeutics, the pioneer in RNA activation therapeutics, today announced the completion of a £23 million Series A equity financing led by aMoon, Israel’s largest healthtech and life sciences venture fund, with participation from existing investors. As part of the Series A financing, Dr Gur Roshwalb, ...

MiNA Therapeutics adds Dr Gur Roshwalb to its Board along with raising £23m Series A financing led by aMoon

MiNA Therapeutics adds Dr Gur Roshwalb to its Board along with raising £23m Series A financing led by aMoon

From:: MiNA Therapeutics adds Dr Gur Roshwalb to its Board along with raising £23m Series A financing led by aMoon

Sorry, the comment form is closed at this time.